RecruitingNot ApplicableNCT06048159
Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke
TACS for the Recovery of Phonological STM After Stroke
Sponsor
Medical College of Wisconsin
Enrollment
120 participants
Start Date
Nov 6, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Diagnosed with left hemisphere stroke/aphasia
- Consent date \>= 1 month after stroke onset
- Fluent in English
- years of age or older
Exclusion Criteria7
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Presence of major untreated or unstable psychiatric disease
- A chronic medical condition that is not treated or is unstable
- The presence of cardiac stimulators or pacemakers
- Contraindications to MRI or tACS, e.g. patients with metallic implants, and/or history of skull fractures, pregnancy, skin diseases
- History of ongoing or unmanaged seizures
- History of dyslexia or other developmental learning disabilities
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEHD-tACS
High definition tACS will be applied during speech therapy.
DEVICESham HD-tACS
Sham high definition tACS will be applied during speech therapy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06048159
Related Trials
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
NCT066159731 location
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
NCT034017621 location
Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
NCT073318961 location
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
NCT0640296811 locations
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT0506521663 locations